One critical focus for Roivant Sciences is its pipeline. Its success is heavily reliant on products like VTAMA, currently ...
The FDA has extended the review period for the sNDA for tapinarof cream, 1% in the treatment of atopic dermatitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback